Skip to main content
. Author manuscript; available in PMC: 2015 Apr 8.
Published in final edited form as: J Urol. 2009 Sep 16;182(5):2274–2278. doi: 10.1016/j.juro.2009.07.024

Table 1.

Needle biopsy findings at progression

No./Total No. (%)
Multiple core (more than 2) involvement 14/48 (29)
GP 4/5 13/48 (27)
More than 50% involvement of core 6/48 (13)
Multiple cores + more than 50% core involvement 6/48 (13)
GP 4/5 + more than 50% involvement of core 4/48 (8)
GP 4/5 + multiple cores 3/48 (6)
All 3 adverse criteria 2/48 (4)
Total 48/48 (100)